Abbott Laboratories (ABT US, +1, 28-April-26)

Philip Boudreau (Executive Vice-President – Chief Financial Officer since 2023, joined 1997) bought 11,109 shares on April 23rd at $91.93, spending $1.1 million. Boundreau has been reportable since at least 2020, and this is his first purchase, and a confident one. 

Prior to the purchase, he owned $6.5 million in stock and over 200,000 options, making it unlikely that he felt pressure to make such a large purchase. 

We have had a positive rank on this stock since late January 2026, based on purchases of $2 million from Robert Ford (Chair & CEO, joined 1996) and $1 million from Daniel Starks (Director since 2017; retired Chair & CEO of St. Jude Medical), both around $107 per share. 

We are renewing our +1 (strongly positive) rank in response to this large purchase from the CFO.

If you want the Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe! Follow us on LinkedIn and Twitter